Finance

Lists
Why is BWAY down 2,78%?
Dive Deeper
BWAY:NASDAQ
Brainsway Ltd - ADR
8,73 US$
-2,78%
(-0,25) 1D
19 ნოე, 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BWAY...
Open
8,81 US$
High
9,02 US$
Low
8,63 US$
Mkt. cap
361,24 მლნ.
Avg. vol.
125,86 ათ.
Volume
119,32 ათ.
P/E ratio
33,16
52-wk high
17,40 US$
52-wk low
7,14 US$
EPS
0,26 US$
Beta
1,36
Shares outstanding
40,26 მლნ.
No. of employees
129
Open
8,81 US$
High
9,02 US$
Low
8,63 US$
Mkt. cap
361,24 მლნ.
Avg. vol.
125,86 ათ.
Volume
119,32 ათ.
P/E ratio
33,16
52-wk high
17,40 US$
52-wk low
7,14 US$
EPS
0,26 US$
Beta
1,36
Shares outstanding
40,26 მლნ.
No. of employees
129
News stories
From web sources and news partners
Profile
BrainsWay Ltd. is an international company that is engaged in the development of a medical device that uses H-coil for deep transcranial magnetic stimulation as a non-invasive treatment for depression, OCD, and smoking addiction. The company was founded in 2003 and has offices in the US and Jerusalem. Wikipedia
About Brainsway Ltd - ADR
CEOჰადარ ლევი | ქრისტოფერ ფონ ჯაკო
Employees129
Founded2003
Headquartersიერუსალიმი, Jerusalem District, ისრაელი
SectorHealth Care
IndustryMedical device
Analyst ratings
Based on 2 analysts giving stock ratings to BWAY in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for BWAY in the last 3 months.
Highest
Current 8,73 US$
20,00 US$ (+129,10%)
Average
19,50 US$ (+123,37%)
Lowest
19,00 US$ (+117,64%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
19,00 US$
+117,6%
11/03/2026
Sam Eiber
BTIG
Buy
Maintained
20,00 US$
+129,1%
10/19/2026
Carl Byrnes
Northland Securities
Buy
Maintained
15,00 US$
+71,8%
01/22/2026
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Reiterated
9,50 US$
+8,8%
11/12/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
13,51 მლნ.
14,54 მლნ.
15,53 მლნ.
17,11 მლნ.
Cost of goods sold
3,35 მლნ.
3,43 მლნ.
3,86 მლნ.
4,34 მლნ.
Cost of revenue
3,35 მლნ.
3,43 მლნ.
3,86 მლნ.
4,34 მლნ.
Research and development expenses
2,40 მლნ.
2,53 მლნ.
2,88 მლნ.
3,22 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,51 მლნ.
6,67 მლნ.
6,79 მლნ.
7,16 მლნ.
Operating expense
8,91 მლნ.
9,20 მლნ.
9,67 მლნ.
10,38 მლნ.
Total operating expenses
12,26 მლნ.
12,63 მლნ.
13,53 მლნ.
14,72 მლნ.
Operating income
1,25 მლნ.
1,92 მლნ.
2,00 მლნ.
2,39 მლნ.
Other non operating income
-
2,52 მლნ.
-
-
EBT including unusual items
1,81 მლნ.
2,54 მლნ.
2,41 მლნ.
2,92 მლნ.
EBT excluding unusual items
1,81 მლნ.
2,54 მლნ.
2,41 მლნ.
2,92 მლნ.
Income tax expense
242,00 ათ.
-334,00 ათ.
120,00 ათ.
208,00 ათ.
Effective tax rate
13,38%
-13,14%
4,98%
7,13%
Other operating expenses
-
-
-
-
Net income
1,57 მლნ.
2,88 მლნ.
2,29 მლნ.
2,71 მლნ.
Net profit margin
11,59%
19,77%
14,74%
15,84%
Earnings per share
0,02
0,06
0,06
0,07
Interest and investment income
1,13 მლნ.
216,00 ათ.
724,00 ათ.
1,41 მლნ.
Interest expense
-571,00 ათ.
-1,53 მლნ.
-319,00 ათ.
-879,00 ათ.
Net interest expenses
555,00 ათ.
-1,32 მლნ.
405,00 ათ.
527,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,66 მლნ.
2,27 მლნ.
2,47 მლნ.
2,83 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google აპები